Effect of stem cell application on Asherman syndrome, an experimental rat model

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 8, 2014, Pages 975-982

  Kilic, Sevtap ^a   Yuksel, Beril ^b   Pinarli, F ^c   Albayrak, A ^d   Boztok, B ^c   Delibasi, T ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b DUMLUPINAR UNIVERSITY   (Turkey)

^c Yildirim Beyazit Training and Research Hospital   (Turkey)

^d Haydarpa a Numune Research and Education Hospital   (Turkey)

Author keywords

Intrauterine adhesion; Intrauterine synechia; Ki 67; PCNA; VEGF

Indexed keywords

CYCLINE; ESTROGEN; VASCULOTROPIN; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; FLOW CYTOMETRY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; UTERUS HORN; UTERUS SYNECHIA; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CELL CULTURE; CYTOLOGY; ENDOMETRIUM; ENZYME IMMUNOASSAY; FIBROSIS; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RAT; VAGINA DISEASE; WISTAR RAT;

RATTUS;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOMETRIUM; FEMALE; FIBROSIS; GYNATRESIA; IMMUNOENZYME TECHNIQUES; INFLAMMATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR;

EID: 84906320664     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0268-2     Document Type: Article

References (29)

1. March CM. Management of Asherman's syndrome. Reprod Biomed Online. 2011;23(1):63-76.
2. Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol. 1996;65(1):109-13. (Pubitemid 26096622)
3. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome - one century later. Fertil Steril. 2008;89:759-79. (Pubitemid 351491241)
4. Foix A, Bruno RO, Davison T, Lema B. The pathology of postcurettage intrauterine adhesions. Am J Obstet Gynecol. 1966;96(7):1027-33.
5. March CM. Intrauterine adhesions. Obstet Gynecol Clin North Am. 1995;22(3):491.
6. Yuksel B, Kilic S, Taser F, Pinarli F, Delibasi T. Male fertility preservation, current options with stem cells. Niche. 2012;1:42-5.
7. Sliwi ñski L, Folwarczna J, Nowiñska B, Cegieła U, Pytlik M, Kaczmarczyk-Sedlak I, et al. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system. Acta Biochim Pol. 2009;56(2):261-70.
8. Fried SK, Moustaid-Moussa N. Culture of adipose tissue and isolated adipocytes. Methods Mol Biol. 2001;155:197-212.
9. Irkorucu O, Ferahköşe Z, Memiş L, Ekinci O, Akin M. Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo). 2009;64(2):143-8.
10. Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Niwa K, Tamaya T. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod. 1998;4(2):173-7. (Pubitemid 28137566)
11. McCampbell AS, Walker CL, Broaddus RR, Cook JD, Davies PJ. Developmental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat. Lab Invest. 2008;88(6):615-26. (Pubitemid 351733276)
12. Li X, Sun H, Lin N, Hou X, Wang J, Zhou B, et al. Regeneration of uterine horns in rats by collagen scaffolds loaded with collagenbinding human basic fibroblast growth factor. Biomaterials. 2011;32(32):8172-81.
13. Robinson JK, Colimon LM, Isaacson KB. Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman's syndrome). Fertil Steril. 2008;90(2):409-14.
14. Abbott J, Thomson A, Vancaillie T. SprayGel following surgery for Asherman's syndrome may improve pregnancy outcome. J Obstet Gynaecol. 2004;24(6):710-1.
15. Amer MI, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006;32(6):559-66. (Pubitemid 44736616)
16. Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS, Tzingounis VA. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res. 2002;63(1):10-4.
17. Polishuk WZ, Adoni A, Aviad I. Intrauterine device in the treatment of traumatic intrauterine adhesions. Fertil Steril. 1969;20(2):241-9.
18. Orhue AA, Aziken ME, Igbefoh JO. A comparison of two adjunctive treatments for intrauterine adhesions following lysis. Int J Gynaecol Obstet. 2003;82(1):49-56. (Pubitemid 36808592)
19. Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;S0301-2115(13):00325-4.
20. Tourgeman D, Gentzchein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol. 1999;180:1480-3. (Pubitemid 29293275)
21. Gargett CE, Masuda H. Adult stem cells in the endometrium. Mol Hum Reprod. 2010;16(11):818-34.
22. Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004;292(1):81-5. (Pubitemid 38923797)
23. Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007;25(8):2082-6. (Pubitemid 47258186)
24. Bratincsák A, Brownstein MJ, Cassiani-Ingoni R, Pastorino S, Szalayova I, Tóth ZE, et al. CD45-positive blood cells give rise to uterine epithelial cells in mice. Stem Cells. 2007;25(11):2820-6. (Pubitemid 350127866)
25. Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome. J Hum Reprod Sci. 2011;4(1):43-8.
26. Zhu X, Shi W, Tai W, Liu F. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derivedMesenchymal stem cells. Cell Tissue Res. 2012;350(2):277-87.
27. Wu J, Li J, Zhang N, Zhang C. Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol. 2011;106(3):317-24.
28. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stemcells to the infarctedmyocardium: feasibility, cellmigration, and body distribution. Circulation. 2003;108(7):863-8. (Pubitemid 37022130)
29. Takehara Y, Yabuuchi A, Ezoe K, Kuroda T, Yamadera R, Sano C, et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest. 2013;93(2):181-93.